Alector (ALEC) Depreciation & Amortization (CF) (2018 - 2026)
Alector (ALEC) reported Depreciation & Amortization (CF) of $1.1 million for Q1 2026, up 9.86% year-over-year from $984000.0 in Q1 2025, and down 7.45% on a QoQ basis from $1.2 million in Q4 2025.
Alector (ALEC) has 9 years of Depreciation & Amortization (CF) data on file, last reported at $1.1 million in Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 9.86% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.8 million (up 17.52% YoY) and the FY2025 annual result came in at $5.7 million, up 5.75% from the prior year.
- Depreciation & Amortization (CF) retreated to $1.1 million in Q1 2026 per ALEC's latest filing, from $1.2 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $2.3 million in Q2 2025 and bottomed at $984000.0 in Q1 2025.
- The 5-year median for Depreciation & Amortization (CF) is $1.4 million (2022), against an average of $1.4 million.
- Peak annual rise in Depreciation & Amortization (CF) reached 65.88% in 2025, while the deepest fall reached 31.81% in 2025.
- Tracing ALEC's Depreciation & Amortization (CF) over 5 years: stood at $1.4 million in 2022, then advanced by 3.08% to $1.4 million in 2023, then declined by 13.57% to $1.2 million in 2024, then decreased by 5.96% to $1.2 million in 2025, then fell by 7.45% to $1.1 million in 2026.
- Per Business Quant, the three latest ALEC Depreciation & Amortization (CF) figures stand at $1.1 million (Q1 2026), $1.2 million (Q4 2025), and $1.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 55.90 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 123.20 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 13.55 Mn |
| 10 | Alector | 238.87 Mn | 32.36 Mn | - | 1.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.08 Mn |
| Mar 31, 2026 | 1.08 Mn |
| Dec 31, 2025 | 1.17 Mn |
| Dec 31, 2025 | 1.17 Mn |
| Sep 30, 2025 | 1.24 Mn |
| Sep 30, 2025 | 1.24 Mn |
| Jun 30, 2025 | 2.33 Mn |
| Jun 30, 2025 | 2.33 Mn |
| Mar 31, 2025 | 984,000.00 |
| Mar 31, 2025 | 984,000.00 |
| Dec 31, 2024 | 1.24 Mn |
| Dec 31, 2024 | 1.24 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Sep 30, 2024 | 1.32 Mn |
| Jun 30, 2024 | 1.40 Mn |
| Jun 30, 2024 | 1.40 Mn |
| Mar 31, 2024 | 1.44 Mn |
| Mar 31, 2024 | 1.44 Mn |
| Dec 31, 2023 | 1.44 Mn |
| Dec 31, 2023 | 1.44 Mn |
| Sep 30, 2023 | 1.46 Mn |
| Sep 30, 2023 | 1.46 Mn |
| Jun 30, 2023 | 1.46 Mn |
| Jun 30, 2023 | 1.46 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Mar 31, 2023 | 1.36 Mn |
| Dec 31, 2022 | 1.39 Mn |
| Dec 31, 2022 | 1.39 Mn |
| Sep 30, 2022 | 1.35 Mn |
| Sep 30, 2022 | 1.35 Mn |
| Jun 30, 2022 | 1.38 Mn |
| Jun 30, 2022 | 1.38 Mn |
| Mar 31, 2022 | 1.59 Mn |
| Mar 31, 2022 | 1.59 Mn |
| Dec 31, 2021 | 1.59 Mn |
| Dec 31, 2021 | 1.59 Mn |
| Sep 30, 2021 | 1.61 Mn |
| Sep 30, 2021 | 1.61 Mn |
| Jun 30, 2021 | 1.59 Mn |
| Jun 30, 2021 | 1.59 Mn |
| Mar 31, 2021 | 1.54 Mn |
| Mar 31, 2021 | 1.54 Mn |
| Dec 31, 2020 | 1.50 Mn |
| Dec 31, 2020 | 1.50 Mn |
| Sep 30, 2020 | 1.46 Mn |
| Sep 30, 2020 | 1.46 Mn |
| Jun 30, 2020 | 1.46 Mn |
| Jun 30, 2020 | 1.46 Mn |
| Mar 31, 2020 | 1.45 Mn |
| Mar 31, 2020 | 1.45 Mn |
| Dec 31, 2019 | 1.38 Mn |
| Dec 31, 2019 | 1.38 Mn |
| Sep 30, 2019 | 1.28 Mn |
| Sep 30, 2019 | 1.28 Mn |
| Jun 30, 2019 | 821,000.00 |
| Jun 30, 2019 | 821,000.00 |
| Mar 31, 2019 | 298,000.00 |
| Mar 31, 2019 | 298,000.00 |
| Dec 31, 2018 | 276,000.00 |
| Dec 31, 2018 | 276,000.00 |
| Sep 30, 2018 | 279,000.00 |
| Sep 30, 2018 | 279,000.00 |
| Jun 30, 2018 | 252,000.00 |
| Jun 30, 2018 | 252,000.00 |
| Mar 31, 2018 | 212,000.00 |
| Mar 31, 2018 | 212,000.00 |